Back to Results

Blueberries Medical Corp (BBRRF)

Blueberries Medical Corp. is a common stock listing on OTC Markets. The company is engaged in cannabis-related activities in Colombia, including the cultivation, growth, and development of medicinal cannabis and related products. Its operations also include the production of psychoactive and non-psychoactive cannabis derivatives, along with the distribution of functional supplements, wellness products, and natural ingredients. Blueberries Medical Corp. is based in Vancouver, Canada.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-BBRR.F
$0.0071
-29.7% Downside
Overvalued
Not available
Not available
Weak
0.0%
November 30, 2026
303.4x
31.3x
6.182 M
6.405 M
4.4%
26.0%
-142.6
54.6%
Valuation • Fair Value

Blueberries Medical Corp (OTC-BBRR.F) Fair Value by Valuation Model

Review the available estimates for Blueberries Medical Corp (OTC-BBRR.F), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$0.0071

Estimated downside of 29.7% versus the current market price.

Fair Value Confidence

Low

Confidence level for the primary fair value estimate.

DCF Fair Value

$0.0066

Discounted cash flow valuation reference.

Comps Fair Value

$0.0073

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Blueberries Medical Corp (OTC-BBRR.F) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Blueberries Medical Corp (OTC-BBRR.F)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

196.155 K

Current operating scale indicator.

Revenue Forecast

222.019 K

Forward revenue estimate.

EBITDA

-497.637 K

Current operating profitability reference.

How to read profitability and growth

This section helps investors review Blueberries Medical Corp (OTC-BBRR.F) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Blueberries Medical Corp (OTC-BBRR.F)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Weak

Financial pressure deserves closer review.

Piotroski Score

3

Weak quality score that deserves closer review.

Beneish M-Score

1,000.00

Higher caution zone on this screen.

Altman Z-Score

-142.6

Lower score that deserves closer risk review.

FCF / Net Income

54.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Blueberries Medical Corp (OTC-BBRR.F). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Blueberries Medical Corp (OTC-BBRR.F)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 30, 2026

Days to Earnings

69

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Blueberries Medical Corp (OTC-BBRR.F), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Blueberries Medical Corp (OTC-BBRR.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Blueberries Medical Corp (OTC-BBRR.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Blueberries Medical Corp (OTC-BBRR.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Blueberries Medical Corp (OTC-BBRR.F) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Neutral

The monthly technical read for Blueberries Medical Corp (OTC-BBRR.F) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Blueberries Medical Corp (OTC-BBRR.F) Stock FAQ

Data-supported answers about Blueberries Medical Corp (OTC-BBRR.F), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$0.0071
Estimated downside 29.7%
Valuation Rating
Overvalued
Estimated downside of 29.7%
Financial Health
Weak
Current financial-health read

The current fair value estimate for Blueberries Medical Corp (OTC-BBRR.F) is $0.0071. This implies an estimated downside of 29.7% versus the current market price.

Based on the current fair value estimate, the stock appears overvalued, with estimated downside of 29.7% versus the current market price.

The current financial health read for Blueberries Medical Corp (OTC-BBRR.F) is Weak. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Blueberries Medical Corp (OTC-BBRR.F) is November 30, 2026.

The latest available data indicates no current dividend yield for Blueberries Medical Corp (OTC-BBRR.F).

The current market capitalization listed for Blueberries Medical Corp is 6.182 M.

The current enterprise value listed for Blueberries Medical Corp is 6.405 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Blueberries Medical Corp is OTC-BBRR.F, and the stock is listed on OTC Markets.

Blueberries Medical Corp (OTC-BBRR.F) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Blueberries Medical Corp is 4.4%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Blueberries Medical Corp is 26.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Pharmaceuticals Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

LLY NYSE Eli Lilly and Company Fair Value Fair Market Cap 1,043 B
JNJ NYSE Johnson & Johnson Fair Value Fair Market Cap 648.7 B
MRK NYSE Merck & Company Inc Fair Value Fair Market Cap 372.3 B
NVS NYSE Novartis AG ADR Fair Value Fair Market Cap 269.8 B
NVO NYSE Novo Nordisk A/S Fair Value Bargain Market Cap 175.3 B
PFE NYSE Pfizer Inc Fair Value Fair Market Cap 159.2 B
BMY NYSE Bristol-Myers Squibb Company Fair Value Fair Market Cap 127.2 B
SNY NASDAQ Sanofi ADR Fair Value Undervalued Market Cap 102 B
GSK NYSE GSK plc DRC Fair Value Undervalued Market Cap 101.9 B
TAK NYSE Takeda Pharmaceutical Co Ltd ADR Fair Value Fair Market Cap 60.536 B
TEVA NYSE Teva Pharma Industries Ltd ADR Fair Value Fair Market Cap 46.053 B
HLN NYSE HALEON PLC ADR Fair Value Fair Market Cap 40.268 B
RPRX NASDAQ Royalty Pharma Plc Fair Value Fair Market Cap 33.639 B
ZTS NYSE Zoetis Inc Fair Value Bargain Market Cap 30.107 B
VTRS NASDAQ Viatris Inc Fair Value Undervalued Market Cap 19.733 B
JAZZ NASDAQ Jazz Pharmaceuticals PLC Fair Value Fair Market Cap 15.616 B
CORT NASDAQ Corcept Therapeutics Incorporated Fair Value Overvalued Market Cap 12.702 B
ELAN NYSE Elanco Animal Health Fair Value Fair Market Cap 11.456 B
AXSM NASDAQ Axsome Therapeutics Inc Fair Value Fair Market Cap 10.639 B
RDY NYSE Dr. Reddy’s Laboratories Ltd ADR Fair Value Fair Market Cap 10.564 B